Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
8.77
-0.36 (-3.94%)
At close: Mar 24, 2026, 4:00 PM EDT
8.88
+0.11 (1.25%)
Pre-market: Mar 25, 2026, 6:40 AM EDT

Telix Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,9712,5375,155---
Market Cap Growth
-48.06%-50.78%----
Enterprise Value
3,2962,8575,073000
Last Close Price
8.777.4915.40---
PE Ratio
--354.98157.79---
PS Ratio
3.703.169.98---
PB Ratio
7.156.1114.61---
P/TBV Ratio
7.136.0915.06---
P/FCF Ratio
--59.03280.56---
P/OCF Ratio
--146.73187.51---
EV/Sales Ratio
4.103.559.82---
EV/EBITDA Ratio
101.5555.8283.91---
EV/EBIT Ratio
170.9195.9591.95---
EV/FCF Ratio
--66.47276.13---
Debt / Equity Ratio
1.111.111.020.110.120.89
Debt / EBITDA Ratio
9.139.135.960.78-0.11-0.03
Debt / FCF Ratio
-10.87-10.8719.601.49-0.15-0.04
Net Debt / Equity Ratio
0.780.78-0.23-0.71-1.32-9.03
Net Debt / EBITDA Ratio
6.356.35-1.32-4.751.150.26
Net Debt / FCF Ratio
-7.57-7.57-4.34-9.051.490.32
Asset Turnover
0.760.760.851.480.860.05
Inventory Turnover
12.4312.4310.1914.0610.713.09
Quick Ratio
1.171.172.571.141.821.10
Current Ratio
1.431.432.781.412.021.25
Return on Equity (ROE)
-1.85%-1.85%14.83%5.40%-252.89%-187.51%
Return on Assets (ROA)
3.83%3.83%8.06%7.93%-52.07%-54.30%
Return on Invested Capital (ROIC)
6.27%6.27%17.81%18.05%-119.10%-106.05%
Return on Capital Employed (ROCE)
3.57%3.57%12.27%7.87%-74.58%-69.07%
Earnings Yield
-0.24%-0.28%0.63%---
FCF Yield
-1.45%-1.69%0.36%---
Buyback Yield / Dilution
-0.07%-0.07%-0.01%---
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q